Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Chimeric IgG monoclonal antibody cG250

EU orphan designation number: EU/3/02/094   
Active ingredient: Chimeric IgG monoclonal antibody cG250
Indication: Treatment of renal cell carcinoma
Sponsor: Heidelberg Pharma AG
Schriesheimer Straße 101, 68526 Ladenburg, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/03/2002 Orphan designation EMEA/OD/052/01 (2002)1230 of 19/03/2002
01/09/2006 Change of name and/or address of sponsor
22/11/2017 Change of name and/or address of sponsor